medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2016; 15 (4)


The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C

Mateos-Muñoz B, Larrad-Sáinz A, Torrejón MJ, Devesa-Medina MJ, Matía-Martín MP, Cárdenas MC, Suárez A, Ortega-Medina L, Rey-Díaz-Rubio E, Ladero JM

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 492-500
Archivo PDF: 203.85 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rivera Irigoin R, Abilés J. Soporte nutricional en el paciente con cirrosis hepática. Gastroenterol Hepatol 2012; 35: 594- 601.

  2. Ismail FW, Khan RA, Kamani L, Wadalawala AA, Shah HA, Hamid SS, Jafri W. Nutritional status in patients with hepatitis C. J Coll Physicians Surg Pak 2012; 22: 139-42.

  3. Wendland BE. Nutritional guidelines for persons infected with the hepatitis C virus: a review of the literature. Can J Diet Pract Res 2001; 62: 7-15.

  4. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpreta tion in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.

  5. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-47.

  6. Witthöft TH, Möller B, Wiedmann KH, Mauss S, Link R, Lohmeyer J, Lafrenz M, et al. Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. J Viral Hepat 2007; 14: 788-96.

  7. Mulasi U, Kuchnia AJ, Cole AJ, Earthman CP. Bioimpedance at the bedside: Current applications, limitations, and opportunities. Nutr Clin Pract 2015; 30: 180-93.

  8. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr 2015; 34: 335-40.

  9. Oliveira LPM, de Jesus RP, Boulhosa RSSB, Mendes CMC, Lyra AC, Lyra LGC. Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who did not have obesity or type 2 diabetes. Clinics 2012; 67: 219-23.

  10. Barbosa-Silva MC, Barros AJ, Wang J, Heymsfield SB, Pierson RN. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005; 82: 49-52.

  11. Kahraman A, Hilsenbeck J, Nyga M, Ertle J, Wree A, Plauth M, Gerken G, et al. Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C. Virol J 2010; 7: 191.

  12. Selberg O, Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002; 86: 509-16.

  13. Antaki F, French MM, Moonka DK, Gordon SC. Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection. Dig Dis Sci 2008; 53: 1957-60.

  14. Fernandes SA, Bassani L, Nunes FF, Aydos MED, Alves AV, Marroni CA. Nutritional assessment in patients with cirrhosis. Arq Gastroenterol 2012; 49: 19-26.

  15. Alam I, Ali I, Ali S, Alam I, Naseem F, Naseem Z. Impact of combination interferon therapy on the body weight, body fat and lean body mass of chronic HCV infected patients. J Antivir Antiretrovir 2013; 6: 1-5.

  16. Moriyama M, Matsumura H, Fukushima A, Ohkido K, Arakawa Y, Nirei K, Yamagami H, et al. Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease. Dig Dis Sci 2006; 51: 1967-77.

  17. Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci 2007; 52: 1595-612.

  18. Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G, Gaudio E, et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16: 785-9.

  19. Guo C-H, Chen P-C, Lin K-P, Shih M-Y, Ko W-S. Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects. Environ Toxicol Pharmacol 2012; 33: 288-96.

  20. Mastoi AA, Devrajani BR, Shah SZ, Rohopoto Q, Memon SA, Baloch M, Qureshi GA, et al. Metabolic investigations in patients with hepatitis B and C. World J Gastroenterol 2010; 16: 603-7.

  21. Grüngreiff K, Hebell T, Gutensohn K, Reinhold A, Reinhold D. Plasma concentrations of zinc, copper, interleukin-6 and interferon- g, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C. Mol Med Rep 2009; 2: 63-8.

  22. Ko WS, Guo CH, Yeh MS, Lin LY, Hsu GSW, Chen PC, Luo MC, et al. Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol 2005; 11: 4697-702.

  23. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010; 55: 513-20.

  24. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-20.

  25. Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of parathyroid hormone- vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010; 4: 634-40.

  26. Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011; 55: 756-61.

  27. Ladero JM, Torrejón MJ, Sánchez-Pobre P, Suárez A, Cuenca F, de la Orden V, Devesa MJ, et al. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C. Ann Hepatol 2013; 12: 199-204.

  28. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, VermehrenJ, Herrman E, et al. Vitamin D deficiency and CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alpha based therapy. J Hepatol 2011; 54: 887-93.

  29. Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, et al. Low vitamin D serum levels related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-67.

  30. Bitetto D, Fattovich G, Fabris C, Ceriani A, Falleti E, Fornasiere E, Pasino M, et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011; 53: 1118-26.

  31. Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina A-R, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011; 17: 5184-90.

  32. Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol 2012; 18: 800-5.

  33. Ji HF, Sun Y, Shen L. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis. Nutrition 2014; 30: 986-91.

  34. Bandara P, George J, McCaughan G, Naidoo D, Lux O, Saloniokas C, Kench J, et al. Antioxidant levels in peripheral blood, disease activity and fibrosis stage in chronic hepatitis C. Liver Int 2005; 25: 518-26.

  35. Kim YN, Cho YO. Vitamin E status of 20- to 59-year-old adults living in the Seoul metropolitan area of South Korea. Nutr Res Pract 2015; 9: 192-8.

  36. Li Y, Wongsiriroj N, Blaner WS. The multifaceted nature of retinoid transport and metabolism. Hepatobiliary Surg Nutr 2014; 3: 126-39.

  37. Christou GA, Tselepis AD, Kiortsis DN. The metabolic role of retinol binding protein 4: an update. Horm Metab Res 2012; 44: 6-14.

  38. Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, et al. RBP-to-retinol ratio, but not the total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes Metab 2009; 11 :204-12.

  39. Jain SK, Pemberton PW, Smith A, McMahon RFT, Burrows PC, Aboutwerat A, Warnes TW. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36: 805-11.

  40. Peres W a. F, Chaves GV, Gonçalves JCS, Ramalho A, Coelho HSM. Vitamin A deficiency in patients with hepatitis C virus- related chronic liver disease. Br J Nutr 2011; 106: 1724-31.

  41. Bitetto D, Bortolotti N, Falleti E, Vescovo S, Fabris C, Fattovich G, Cusshig A, et al. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. Hepatology 2013; 57: 925-33.

  42. Mourey MS, Siegenthaler G, Amédée-Manesme O. Regulation of metabolism of retinol-binding protein by vitamin A status in children with biliary atresia. Am J Clin Nutr 1990; 51: 638-43.

  43. Kotnik P, Fischer-Posovszky P, Wabistch M. RBP4: a controversial adipokine. Eur J Endocrinol 2011; 165: 703-11.

  44. Gruys E, Toussaints MJM, Niewold TA, Koopman SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005; 6: 1045-56.




2020     |     www.medigraphic.com